Durable alteration of the colonic microbiota by the administration of donor fecal flora

Journal of Clinical Gastroenterology

Volumn 44, Issue 8, 2010, Pages 551-561

  Grehan, Martin J ^a   Borody, Thomas Julius ^b   Leis, Sharyn M ^c   Campbell, Jordana ^b   Mitchell, Hazel ^d   Wettstein, Antony ^b  

^a NEPEAN HOSPITAL   (Australia)

^b Centre for Digestive Diseases   (Australia)

^c Probiotic Therapy Research Centre   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Clostridium; fecal bacteriotherapy; implantation; probiotic

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; AZATHIOPRINE; BETA INTERFERON; BISACODYL; BISMUTH; COLCHICINE; DOXYCYCLINE; ESOMEPRAZOLE; GLYCOPREP; LACTULOSE; LISINOPRIL; MACROGOL; MESALAZINE; METRONIDAZOLE; PANTOPRAZOLE; RIFAMPICIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON FLORA; CONSTIPATION; CONTROLLED STUDY; CROHN DISEASE; DIARRHEA; DONOR; FECES ANALYSIS; FECES BACTERIOTHERAPY; FECES MICROFLORA; FEMALE; HUMAN; IMPLANTATION; IRRITABLE COLON; MALE; PRIORITY JOURNAL;

ADULT; COLON; CONSTIPATION; CROHN DISEASE; DIARRHEA; FECES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 77955961892     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181e5d06b     Document Type: Article

References (37)

1. Borody TJ, Warren EF, Leis SM, et al. Bacteriotherapy using fecal flora; Toying with human motions. J Clin Gastroenterol. 2004;38:475-483.
2. Eiseman B, Silen W, Bascom GS, et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery. 1958;44:854-859.
3. Bowden TA, Mansberger AR, Lykins LE. Pseudomembranous enterocolitis: mechanism of restoring floral homeostasis. Am Surg. 1981;47:178-183.
4. Gustafsson A, Lund-Tonnesen S, Berstad A, et al. Fecal shortchain fatty acids in patients with antibiotic-associated diarrhea, before and after fecal enema treatment. Scand J Gastroenterol. 1998;33:721-727.
5. Paterson DL, Iredell J, Whitby M. Putting back the bugs: bacterial treatment relieves chronic diarrhea. Med J Aust. 1994;160:232-233.
6. Persky SE, Brandt LJ. Treatment of recurrent Clostridium difficile-associated diarrhea by administration of donated stool directly through a colonoscope. Am J Gastroenterol. 2000; 95:3283-3285.
7. Schwan A, Sjolin S, Trottestam U, et al. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal feces. Scand J Infect Dis. 1984;16:211-215.
8. Borody TJ, Warren EF, Leis S, et al. Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol. 2003; 37:42-47.
9. Bennet JD, Brinkman M. Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet. 1989;1:164.
10. Dendukuri N, Costa V, McGregor, et al. The use of probiotics in the prevention and treatment of Clostridium difficile diarrhea [McGill University Health Centre website]. 2005. Available at: http://www.mcgill.ca/files/tau/ PROBIOTICS-Report-5Final.pdf. [Accessed on: May 2, 2008].
11. Bezkorovainy A. Probiotics: determinants of survival and growth in the gut. Am J Clin Nutr. 2001;73 (2 suppl): 399S-405S.
12. Tvede M, Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhea in six patients. Lancet 1989;1:1156-1160.
13. Albert MJ, Bhat P, Rajan D, et al. Fecal flora of South Indian infants and young children in health and with acute gastroenteritis. J Med Microbiol. 1978;11:137-143.
14. Gorbach SL, Neale G, Levitan R, et al. Alterations in human intestinal microflora during experimental diarrhea. Gut. 1970;11:1.
15. Cole JR, Chai B, Marsh TL, et al. The Ribosomal Database Project (RDP-II): previewing a new autoaligner that allows regular updates and the new prokaryotic taxonomy. Nucleic Acids Res. 2003;31:442-443.
16. Ashelford KE, Weightman AJ, Fry JC. PRIMROSE: a computer program for generating and estimating the phylogenetic range of 16S rRNA oligonucleotide probes and primers in conjunction with the RDP-II database. Nucleic Acids Res. 2002;30:3481-3489.
17. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994; 22:4673-4680.
18. Nubel U, Engelen B, Felske A, et al. Sequence heterogeneities of genes encoding 16S rRNAs in Paenibacillus polymyxa detected by temperature gradient gel electrophoresis. J Bacteriol. 1996;178:5636-5643.
19. Satokari RM, Vaughan EE, Akkermans AD, et al. Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing gradient gel electrophoresis. Appl Environ Microbiol. 2001;67:504-513.
20. Heilig HGHJ, Zoetendal EG, Vaughan EE, et al. Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Appl Environ Microbiol. 2002;68: 114-123.
21. Zoetendal EG, Akkermans ADL, De Vos WM. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host specific communities of active bacteria. Appl Environ Microbiol. 1998;64:3854-3859.
22. Majamaa H, Isolauri E, Saxelin M, et al. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr. 1995;20:333-339.
23. Tannock GW, Munro K, Harmsen HJM, et al. Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus. Appl Environ Microbiol. 2000;66:2578-2578
24. Walter J, Hertel C, Tannock GW, et al. Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl Environ Microbiol. 2001;67:2578-2585.
25. Hopkins M, Macfarlane G. Nondigestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro. Appl Environ Microbiol. 2003;69:1920-1927.
26. Van den Bogaard AE, Weidema WF, van Boven CP, et al. Recolonization and colonization resistance of the large bowel after three methods of preoperative preparation of the gastrointestinal tract for elective colorectal surgery. J Hyg. 1986;97:49-59.
27. Van der Waaij D, Berghuis-de Vries JM, Lekkerkerk-van der Wees JEC. Colonization resistance of the digestive tract in conventional and antibiotic treated mice. J Hyg. 1971; 69:405-411.
28. Van der Waaij D, Berghuis JM. Determination of the colonization resistance of the digestive tract of individual mice. J Hyg. 1973;72:379-387.
29. Koopman JP, Kennis HM, van Druten JAM. Colonization resistance of the digestive tract and gastrointestinal transit time in SPF mice. Lab Anim. 1978;12:223-226.
30. Guarner F, Schaafsma GJ. Probiotics. Int J Food Microbiol. 1998;39:237-238.
31. Pochapin M. The effect of probiotics on Clostridium difficile diarrhea. Am J Gastroenterol. 2000;95:S11-S13.
32. Sen S, Mullan MM, Parker TJ, et al. Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Dig Dis Sci. 2002;47:2615-2620.
33. Kim HJ, Camilleri M, McKinzie S, et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2003;17:895-904.
34. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119:305-309.
35. Gionchetti P, Rizzello F, Helwig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebocontrolled trial. Gastroenterology. 2003;124:1202-1209.
36. Vollaard EJ, Clasener HAL. Colonization resistance. Antimicrob Agents Chemother. 1994;38:409-414.
37. Johansson M-L, Molin G, Jeppsson B, et al. Administration of different Lactobacillus strains in fermented oatmeal soup: in vivo colonization of human intestinal mucosa and effect on the indigenous flora. Appl Environ Microbiol. 1993;59:15-20.